Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis
- PMID: 21496568
- DOI: 10.1016/B978-0-444-52014-2.00001-X
Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis
Abstract
HD is a complex illness, with a broad clinical picture that begins years before clear motor onset and evolves over decades to a terminal state of extreme disability. It challenges the resources of families and communities and the skills of medical and ancillary health care providers. A broader understanding of the phenotypes, progression, and genetic basis of HD may elevate the standard of care for these deserving patients.
Similar articles
-
Huntington's disease: clinical presentation and treatment.Int Rev Neurobiol. 2011;98:297-323. doi: 10.1016/B978-0-12-381328-2.00013-4. Int Rev Neurobiol. 2011. PMID: 21907093 Review.
-
Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease.Exp Neurol. 2008 Sep;213(1):137-44. doi: 10.1016/j.expneurol.2008.05.017. Epub 2008 Jul 11. Exp Neurol. 2008. PMID: 18588876
-
Excessive blinking as an initial manifestation of juvenile Huntington's disease.Neurol Sci. 2008 Sep;29(4):275-7. doi: 10.1007/s10072-008-0981-7. Epub 2008 Sep 20. Neurol Sci. 2008. PMID: 18810605
-
Autopsy-proven Huntington's disease with 29 trinucleotide repeats.Mov Disord. 2007 Jan;22(1):127-30. doi: 10.1002/mds.21195. Mov Disord. 2007. PMID: 17115386
-
[From gene to disease; HD gene and Huntington disease].Ned Tijdschr Geneeskd. 2001 Nov 3;145(44):2120-3. Ned Tijdschr Geneeskd. 2001. PMID: 11723754 Review. Dutch.
Cited by
-
Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network-based screening approach.J Cell Mol Med. 2024 Aug;28(16):e18588. doi: 10.1111/jcmm.18588. J Cell Mol Med. 2024. PMID: 39153206 Free PMC article.
-
Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.Free Radic Biol Med. 2013 Sep;62:102-110. doi: 10.1016/j.freeradbiomed.2013.04.017. Epub 2013 Apr 18. Free Radic Biol Med. 2013. PMID: 23602907 Free PMC article. Review.
-
Neurotheranostics as personalized medicines.Adv Drug Deliv Rev. 2019 Aug;148:252-289. doi: 10.1016/j.addr.2018.10.011. Epub 2018 Oct 26. Adv Drug Deliv Rev. 2019. PMID: 30421721 Free PMC article. Review.
-
A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease.PLoS One. 2014 Feb 4;9(2):e87923. doi: 10.1371/journal.pone.0087923. eCollection 2014. PLoS One. 2014. PMID: 24503862 Free PMC article.
-
The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum-microglia crosstalk preventing disease progression in a mouse model of Huntington's disease.Cell Death Dis. 2020 Jul 18;11(7):546. doi: 10.1038/s41419-020-02754-w. Cell Death Dis. 2020. PMID: 32683420 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical